Elevance Health Projects Steady Q1 Earnings, Confirms 2025 Outlook

Elevance Health reported preliminary first-quarter results that exceeded analyst expectations, projecting adjusted earnings of $11.97 per share, above consensus estimates. The company's medical cost trends, including those in its Medicare Advantage segment, were elevated but remained in line with expectations and pricing strategies. Unlike UnitedHealth, which cut its outlook and missed earnings due to higher-than-expected medical costs, Elevance maintained its full-year profit guidance and Medicare Advantage membership targets. Despite sector-wide stock declines following UnitedHealth's report, Elevance affirmed its financial health and outlook, anticipating adjusted earnings for the year between $34.15 and $34.85 per share. The company will provide more detailed results and guidance updates on April 22, 2025.